Investing
The company, in partnership with Microsoft, aims to develop cancer medicines, followed by treatments for autoimmune diseases and rare conditions.
The funds will be used to strengthen the development of its proprietary AI and enhance technology-enabled delivery of clinical trials.
The financing will be used to execute the company's long-term growth initiatives centered on high-margin, scalable recurring revenues across B2B and pharma channels.
Also, Aevice Health from Singapore has obtained new investment for its global expansion.
KOSDAQ-listed company JLK's CEO Dong-Min Kim explains how they intend to capture the world's largest medical imaging market this year.
Mudit Garg, CEO of Qventus, sat down with MobiHealthNews in San Francisco to discuss the company's $105 million funding round announced today.
Josh Sackman, president and cofounder of AppliedVR, provides MobiHealthNews with an overview of the medical XR space. He focuses on the challenges and progress in the sector.
The Series F funding round brings the company's total raise to $675 million.
The company also launched the AI Agent App Store for clinicians to collaborate with Hippocratic AI to design AI agents for patient care and operational efficiency.
Qualified Health secures $30 million to develop genAI in healthcare, VitVio raised $2 million in pre-seed funding, and Allumia Ventures spins off from Providence to become VC firm.